Susan M. OBrien, MD Medical Director of the Sue and Ralph Stern Center for Cancer Clinical Trials and Research UC Irvine talks about the Adverse Events with Idelalisib + Rituximab May Be Autoimmune Related from ASH 2015
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content